SARS-CoV-2 infection is associated with higher odds of insulin treatment but not with hemoglobin A1c at 120 days in U.S. Veterans with new-onset diabetes.
Pandora L WanderElliott LowyAnna KorpakLauren A BesteSteven E KahnEdward J Boyko
Published in: Diabetes epidemiology and management (2023)
SARS-CoV-2 is associated with higher odds of insulin treatment but not with higher A1c. Vaccination may be protective.